公开(公告)号：US20180092582A1

公开(公告)日：2018-04-05

申请号：US15832055

申请日：2017-12-05

申请人： Magnolia Medical Technologies, Inc.

发明人： Richard G. Patton

IPC分类号： A61B5/15 ,  B01L3/00

CPC分类号： A61B5/150221 ,  A61B5/1422 ,  A61B5/1438 ,  A61B5/15003 ,  A61B5/150099 ,  A61B5/150251 ,  A61B5/150343 ,  A61B5/150389 ,  A61B5/150473 ,  A61B5/150503 ,  A61B5/150755 ,  A61B5/150977 ,  A61B5/150992 ,  A61B5/153 ,  A61B5/154 ,  A61B5/1545 ,  A61B5/155 ,  A61B10/0045 ,  A61B10/0048 ,  A61B10/0051 ,  A61B10/007 ,  A61B10/0096 ,  A61B10/0233 ,  A61B2010/0061 ,  A61B2010/0077 ,  B01L3/502 ,  B01L2200/026 ,  B01L2200/141 ,  B01L2300/0672 ,  B01L2400/082

摘要： The present invention is directed to the parenteral procurement of bodily-fluid samples. The present invention is also directed to systems and methods for parenterally procuring bodily-fluid samples with reduced contamination from dermally-residing microbes. In some embodiments, a bodily-fluid withdrawing system is used to withdraw bodily fluid from a patient for incubation in culture media in one or more sample vessels. Prior to withdrawing bodily fluid into the one or more sample vessels for incubation, an initial volume of withdrawn bodily fluid is placed in one or more pre-sample reservoirs and is not used for the incubation in culture media.

公开(公告)号：US20180078186A1

公开(公告)日：2018-03-22

申请号：US15829023

申请日：2017-12-01

申请人： Magnolia Medical Technologies, Inc.

发明人： Richard G. Patton

IPC分类号： A61B5/15 ,  B01L3/00

CPC分类号： A61B5/150221 ,  A61B5/1422 ,  A61B5/1438 ,  A61B5/15003 ,  A61B5/150099 ,  A61B5/150251 ,  A61B5/150343 ,  A61B5/150389 ,  A61B5/150473 ,  A61B5/150503 ,  A61B5/150755 ,  A61B5/150977 ,  A61B5/150992 ,  A61B5/153 ,  A61B5/154 ,  A61B5/1545 ,  A61B5/155 ,  A61B10/0045 ,  A61B10/0048 ,  A61B10/0051 ,  A61B10/007 ,  A61B10/0096 ,  A61B10/0233 ,  A61B2010/0061 ,  A61B2010/0077 ,  B01L3/502 ,  B01L2200/026 ,  B01L2200/141 ,  B01L2300/0672 ,  B01L2400/082

摘要： The present invention is directed to the parenteral procurement of bodily-fluid samples. The present invention is also directed to systems and methods for parenterally procuring bodily-fluid samples with reduced contamination from dermally-residing microbes. In some embodiments, a bodily-fluid withdrawing system is used to withdraw bodily fluid from a patient for incubation in culture media in one or more sample vessels. Prior to withdrawing bodily fluid into the one or more sample vessels for incubation, an initial volume of withdrawn bodily fluid is placed in one or more pre-sample reservoirs and is not used for the incubation in culture media.

公开(公告)号：US09872645B2

公开(公告)日：2018-01-23

申请号：US15435684

申请日：2017-02-17

申请人： Magnolia Medical Technologies, Inc.

发明人： Richard G. Patton

IPC分类号： A61B5/15

CPC分类号： A61B5/150221 ,  A61B5/1422 ,  A61B5/1438 ,  A61B5/15003 ,  A61B5/150099 ,  A61B5/150251 ,  A61B5/150343 ,  A61B5/150389 ,  A61B5/150473 ,  A61B5/150503 ,  A61B5/150755 ,  A61B5/150977 ,  A61B5/150992 ,  A61B5/153 ,  A61B5/154 ,  A61B5/1545 ,  A61B5/155 ,  A61B10/0045 ,  A61B10/0048 ,  A61B10/0051 ,  A61B10/007 ,  A61B10/0096 ,  A61B10/0233 ,  A61B2010/0061 ,  A61B2010/0077 ,  B01L3/502 ,  B01L2200/026 ,  B01L2200/141 ,  B01L2300/0672 ,  B01L2400/082

摘要： The present invention is directed to the parenteral procurement of bodily-fluid samples. The present invention is also directed to systems and methods for parenterally procuring bodily-fluid samples with reduced contamination from dermally-residing microbes. In some embodiments, a bodily-fluid withdrawing system is used to withdraw bodily fluid from a patient for incubation in culture media in one or more sample vessels. Prior to withdrawing bodily fluid into the one or more sample vessels for incubation, an initial volume of withdrawn bodily fluid is placed in one or more pre-sample reservoirs and is not used for the incubation in culture media.

公开(公告)号：US09855002B2

公开(公告)日：2018-01-02

申请号：US15432310

申请日：2017-02-14

申请人： Magnolia Medical Technologies, Inc.

发明人： Richard G. Patton

IPC分类号： A61B5/15 ,  A61B5/154 ,  A61B5/155 ,  A61B10/00

CPC分类号： A61B5/150221 ,  A61B5/1422 ,  A61B5/1438 ,  A61B5/15003 ,  A61B5/150099 ,  A61B5/150251 ,  A61B5/150343 ,  A61B5/150389 ,  A61B5/150473 ,  A61B5/150503 ,  A61B5/150755 ,  A61B5/150977 ,  A61B5/150992 ,  A61B5/153 ,  A61B5/154 ,  A61B5/1545 ,  A61B5/155 ,  A61B10/0045 ,  A61B10/0048 ,  A61B10/0051 ,  A61B10/007 ,  A61B10/0096 ,  A61B10/0233 ,  A61B2010/0061 ,  A61B2010/0077 ,  B01L3/502 ,  B01L2200/026 ,  B01L2200/141 ,  B01L2300/0672 ,  B01L2400/082

摘要： The present invention is directed to the parenteral procurement of bodily-fluid samples. The present invention is also directed to systems and methods for parenterally procuring bodily-fluid samples with reduced contamination from dermally-residing microbes. In some embodiments, a bodily-fluid withdrawing system is used to withdraw bodily fluid from a patient for incubation in culture media in one or more sample vessels. Prior to withdrawing bodily fluid into the one or more sample vessels for incubation, an initial volume of withdrawn bodily fluid is placed in one or more pre-sample reservoirs and is not used for the incubation in culture media.

公开(公告)号：US09855001B2

公开(公告)日：2018-01-02

申请号：US15457082

申请日：2017-03-13

申请人： Magnolia Medical Technologies, Inc.

发明人： Richard G. Patton

IPC分类号： A61B5/15 ,  B01L3/00

CPC分类号： A61B5/150221 ,  A61B5/1422 ,  A61B5/1438 ,  A61B5/15003 ,  A61B5/150099 ,  A61B5/150251 ,  A61B5/150343 ,  A61B5/150389 ,  A61B5/150473 ,  A61B5/150503 ,  A61B5/150755 ,  A61B5/150977 ,  A61B5/150992 ,  A61B5/153 ,  A61B5/154 ,  A61B5/1545 ,  A61B5/155 ,  A61B10/0045 ,  A61B10/0048 ,  A61B10/0051 ,  A61B10/007 ,  A61B10/0096 ,  A61B10/0233 ,  A61B2010/0061 ,  A61B2010/0077 ,  B01L3/502 ,  B01L2200/026 ,  B01L2200/141 ,  B01L2300/0672 ,  B01L2400/082

摘要： The present invention is directed to the parenteral procurement of bodily-fluid samples. The present invention is also directed to systems and methods for parenterally procuring bodily-fluid samples with reduced contamination from dermally-residing microbes. In some embodiments, a bodily-fluid withdrawing system is used to withdraw bodily fluid from a patient for incubation in culture media in one or more sample vessels. Prior to withdrawing bodily fluid into the one or more sample vessels for incubation, an initial volume of withdrawn bodily fluid is placed in one or more pre-sample reservoirs and is not used for the incubation in culture media.

公开(公告)号：US09730624B2

公开(公告)日：2017-08-15

申请号：US14328892

申请日：2014-07-11

申请人： Seventh Sense Biosystems, Inc.

发明人： Javier Gonzalez-Zugasti ,  A. David Boccuti ,  Donald E. Chickering, III ,  Mark Michelman ,  Ramin Haghgooie ,  Shawn Davis ,  Scott James ,  Maisam Dadgar ,  Greg Fisher ,  Richard L. Miller ,  Christopher J. Morse ,  Howard Bernstein ,  Douglas A. Levinson

IPC分类号： A61B5/00 ,  A61B5/15 ,  A61B5/151 ,  A61B10/00 ,  A61M37/00 ,  A61B5/154 ,  G06F19/00 ,  A61B5/145 ,  A61B5/1459 ,  A61B5/1486

CPC分类号： A61B5/150374 ,  A61B5/1411 ,  A61B5/14532 ,  A61B5/14539 ,  A61B5/14546 ,  A61B5/1459 ,  A61B5/14865 ,  A61B5/150022 ,  A61B5/150099 ,  A61B5/150221 ,  A61B5/150358 ,  A61B5/150412 ,  A61B5/150503 ,  A61B5/150755 ,  A61B5/150969 ,  A61B5/150977 ,  A61B5/150984 ,  A61B5/151 ,  A61B5/15113 ,  A61B5/15117 ,  A61B5/15144 ,  A61B5/154 ,  A61B5/411 ,  A61B5/685 ,  A61B10/0045 ,  A61B10/0051 ,  A61B10/007 ,  A61B2010/008 ,  A61M37/0015 ,  G06F19/00 ,  G16H10/40

摘要： The present invention generally relates to receiving bodily fluid through a device opening. In one aspect, the device includes a flow activator arranged to cause fluid to be released from a subject. A deployment actuator may actuate the flow activator in a deployment direction, which may in turn cause fluid release from a subject. The flow activator may also be moved in a retraction direction by a retraction actuator. In one aspect, the device may include a vacuum source that may help facilitate fluid flow into the opening of the device and/or may help facilitate fluid flow from the opening to a storage chamber. In one aspect, a device actuator may enable fluid communication between the opening and the vacuum source and the flow activator may be actuated after the enablement of fluid communication.

公开(公告)号：US20170181683A1

公开(公告)日：2017-06-29

申请号：US15457082

申请日：2017-03-13

申请人： Magnolia Medical Technologies, Inc.

发明人： Richard G. PATTON

IPC分类号： A61B5/15 ,  B01L3/00

CPC分类号： A61B5/150221 ,  A61B5/1422 ,  A61B5/1438 ,  A61B5/15003 ,  A61B5/150099 ,  A61B5/150251 ,  A61B5/150343 ,  A61B5/150389 ,  A61B5/150473 ,  A61B5/150503 ,  A61B5/150755 ,  A61B5/150977 ,  A61B5/150992 ,  A61B5/153 ,  A61B5/154 ,  A61B5/1545 ,  A61B5/155 ,  A61B10/0045 ,  A61B10/0048 ,  A61B10/0051 ,  A61B10/007 ,  A61B10/0096 ,  A61B10/0233 ,  A61B2010/0061 ,  A61B2010/0077 ,  B01L3/502 ,  B01L2200/026 ,  B01L2200/141 ,  B01L2300/0672 ,  B01L2400/082

摘要： The present invention is directed to the parenteral procurement of bodily-fluid samples. The present invention is also directed to systems and methods for parenterally procuring bodily-fluid samples with reduced contamination from dermally-residing microbes. In some embodiments, a bodily-fluid withdrawing system is used to withdraw bodily fluid from a patient for incubation in culture media in one or more sample vessels. Prior to withdrawing bodily fluid into the one or more sample vessels for incubation, an initial volume of withdrawn bodily fluid is placed in one or more pre-sample reservoirs and is not used for the incubation in culture media.

公开(公告)号：US20160213294A1

公开(公告)日：2016-07-28

申请号：US15088842

申请日：2016-04-01

申请人： Magnolia Medical Technologies, Inc.

发明人： RICHARD G. PATTON

IPC分类号： A61B5/15

CPC分类号： A61B5/150221 ,  A61B5/1422 ,  A61B5/1438 ,  A61B5/15003 ,  A61B5/150099 ,  A61B5/150251 ,  A61B5/150343 ,  A61B5/150389 ,  A61B5/150473 ,  A61B5/150503 ,  A61B5/150755 ,  A61B5/150977 ,  A61B5/150992 ,  A61B5/153 ,  A61B5/154 ,  A61B5/1545 ,  A61B5/155 ,  A61B10/0045 ,  A61B10/0048 ,  A61B10/0051 ,  A61B10/007 ,  A61B10/0096 ,  A61B10/0233 ,  A61B2010/0061 ,  A61B2010/0077 ,  B01L3/502 ,  B01L2200/026 ,  B01L2200/141 ,  B01L2300/0672 ,  B01L2400/082

摘要： The present invention is directed to the parenteral procurement of bodily-fluid samples. The present invention is also directed to systems and methods for parenterally procuring bodily-fluid samples with reduced contamination from dermally-residing microbes. In some embodiments, a bodily-fluid withdrawing system is used to withdraw bodily fluid from a patient for incubation in culture media in one or more sample vessels. Prior to withdrawing bodily fluid into the one or more sample vessels for incubation, an initial volume of withdrawn bodily fluid is placed in one or more pre-sample reservoirs and is not used for the incubation in culture media.

公开(公告)号：US20150057510A1

公开(公告)日：2015-02-26

申请号：US14513327

申请日：2014-10-14

申请人： Seventh Sense Biosystems, Inc.

发明人： Douglas A. Levinson ,  Howard Bernstein ,  Donald E. Chickering, III ,  Shawn Davis ,  Ramin Haghgooie

IPC分类号： A61B5/15 ,  A61B10/00 ,  A61B5/00 ,  A61B5/157

CPC分类号： A61B5/150984 ,  A61B5/14514 ,  A61B5/14532 ,  A61B5/150022 ,  A61B5/150099 ,  A61B5/150221 ,  A61B5/150229 ,  A61B5/150297 ,  A61B5/150305 ,  A61B5/150389 ,  A61B5/150412 ,  A61B5/150503 ,  A61B5/150755 ,  A61B5/150969 ,  A61B5/150977 ,  A61B5/15105 ,  A61B5/15113 ,  A61B5/15117 ,  A61B5/15123 ,  A61B5/15125 ,  A61B5/15144 ,  A61B5/15186 ,  A61B5/157 ,  A61B5/74 ,  A61B10/0045 ,  A61B2010/008

摘要： The present invention is generally directed to systems and methods for sampling fluids from subjects. The fluid may be any suitable bodily fluid, e.g., blood or interstitial fluid. In some cases, the subject is a patient. The subject may have a device that can be applied to the skin of the subject (e.g., by the subject, or another person), and the device is able to obtain a sample of fluid. The fluid may be stored within a reservoir in the device, and the fluid may be obtained from the subject at any convenient time, e.g., at home, away from a healthcare setting, etc. In some embodiments, the device, or a portion thereof, may be returned to a clinical and/or laboratory setting to analyze the fluid stored within the device.

摘要翻译： 本发明总体上涉及用于从主体取样流体的系统和方法。 流体可以是任何合适的体液，例如血液或间质液。 在某些情况下，受试者是患者。 受试者可以具有可以应用于受试者的皮肤（例如受试者或其他人）的装置，并且该装置能够获得流体样本。 流体可以存储在装置中的储存器中，并且可以在任何方便的时间（例如在家中，远离保健设置等）从受试者获得流体。在一些实施例中，装置或其一部分 ，可以返回到临床和/或实验室设置以分析存储在装置内的流体。

公开(公告)号：US08876734B2

公开(公告)日：2014-11-04

申请号：US14089267

申请日：2013-11-25

申请人： Magnolia Medical Technologies, Inc.

发明人： Richard G. Patton

IPC分类号： A61B5/00 ,  B65D81/00 ,  A61B5/153 ,  A61B5/15 ,  A61B10/00 ,  A61B10/02

CPC分类号： A61B5/150221 ,  A61B5/1422 ,  A61B5/1438 ,  A61B5/15003 ,  A61B5/150099 ,  A61B5/150251 ,  A61B5/150343 ,  A61B5/150389 ,  A61B5/150473 ,  A61B5/150503 ,  A61B5/150755 ,  A61B5/150977 ,  A61B5/150992 ,  A61B5/153 ,  A61B5/154 ,  A61B5/1545 ,  A61B5/155 ,  A61B10/0045 ,  A61B10/0048 ,  A61B10/0051 ,  A61B10/007 ,  A61B10/0096 ,  A61B10/0233 ,  A61B2010/0061 ,  A61B2010/0077 ,  B01L3/502 ,  B01L2200/026 ,  B01L2200/141 ,  B01L2300/0672 ,  B01L2400/082

摘要： The present invention is directed to the parenteral procurement of bodily-fluid samples. The present invention is also directed to systems and methods for parenterally procuring bodily-fluid samples with reduced contamination from dermally-residing microbes. In some embodiments, a bodily-fluid withdrawing system is used to withdraw bodily fluid from a patient for incubation in culture media in one or more sample vessels. Prior to withdrawing bodily fluid into the one or more sample vessels for incubation, an initial volume of withdrawn bodily fluid is placed in one or more pre-sample reservoirs and is not used for the incubation in culture media.